See every side of every news story

Published 4 days ago • loading... • Updated 4 days ago

Nouryon to double capacity for peptide-based drugs - B2B Central

Summary by B2B Central

To meet growing demand for peptide-based diabetes and obesity treatments, Nouryon is doubling production capacity of Kromasil® chromatography media in Sweden. The global specialty chemicals producer, Nouryon announced the expansion of its Kromasil® chromatography media manufacturing facility in Bohus, Sweden. Construction will begin soon in 2025, and the start of production is expected in early 2027. This expansion will double the facility’s cap…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Nouryon to double capacity for peptide-based drugs - B2B Central

To meet growing demand for peptide-based diabetes and obesity treatments, Nouryon is doubling production capacity of Kromasil® chromatography media in Sweden. The global specialty chemicals producer, Nouryon announced the expansion of its Kromasil® chromatography media manufacturing facility in Bohus, Sweden. Construction will begin soon in 2025, and the start of production is expected in early 2027. This expansion will double the facility’s cap…

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated4 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

B2B Central broke the news in 4 days ago on Thursday, February 20, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics